Picture of Ipsen SA logo

IPN Ipsen SA News Story

0.000.00%
fr flag iconLast trade - 00:00
HealthcareBalancedLarge CapHigh Flyer

Brief: Ipsen FY Revenue EUR 3,675.9 Million

Feb 12 (Reuters) - Ipsen SA IPN.PA:

IPSEN FY REVENUE EUR 3,675.9 MILLION VERSUS. IBES ESTIMATE EUR 3,785 MILLION

IPSEN FY ADJUSTED EPS EUR 12.09 VERSUS. IBES ESTIMATE EUR 11.2

IPSEN FY ADJUSTED EBIT MARGIN 35.2%

IPSEN FY EPS EUR 5.32

IPSEN FY EBIT MARGIN 17%

IPSEN SA - OUTLOOK 2026: TOTAL SALES GROWTH GREATER THAN 13.0% AT CER

IPSEN SA - OUTLOOK 2026: CORE OPERATING MARGIN GREATER THAN 35.0% OF TOTAL SALES

IPSEN SA - WE ANTICIPATE FIVE REGULATORY AND CLINICAL MILESTONES THIS YEAR AND TO FURTHER DELIVER ON OUR EXTERNAL INNOVATION STRATEGY - CEO

IPSEN SA - NO LONGER EXPECTS TO ACHIEVE EUR 500M PEAK SALES FOR ONIVYDE AND TAZVERIK

IPSEN SA - IS HIGHLY CONFIDENT ON ITS 2027 MID-TERM OUTLOOK TO EXCEED TOTAL-SALES AVERAGE GROWTH OF AT LEAST 7% PER YEAR FOR PERIOD 2023-27

IPSEN SA - CONFIRMS TARGET OF CORE OPERATING MARGIN IN 2027 OF AT LEAST 32% OF TOTAL SALES

Source text: ID:nGNEb7yqqS

Further company coverage: IPN.PA

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on Ipsen SA

See all news